Jan 2026 ANVISA GMP renewed for Tarapur facility Read more

Contact

One plant. One point of contact for every enquiry.

Naprod Life Sciences Pvt. Ltd. manufactures at a single site — MIDC Tarapur, Boisar, Maharashtra, India (DUNS 915076185). Route your enquiry by type below, or reach the Tarapur facility directly for regulatory and quality correspondence.

163 products, 6 accreditations independently verified against official regulator sources, one manufacturing address since 1994.

Before you write

Route your enquiry — it gets a faster, more relevant answer

Naprod handles four recurring enquiry types: (1) export/regulatory — dossier status, CoA, market registration support for FDF or API products; (2) CDMO/partnership — process development and manufacturing-scale enquiries; (3) product complaints and adverse-event reports — routed to the pharmacovigilance path below, never through the general enquiry form; (4) careers — see current openings on the Careers page. Selecting the right category on the enquiry form below shortens the reply cycle; misrouted regulatory or pharmacovigilance enquiries are the most common cause of delay.

Registered office

Corporate correspondence

[Address pending — company input]

Maharashtra, India

Phone
[Phone pending — company input]

Pending approval Registered-office street address, phone, and general email shown on this card are clearly-labeled stand-ins pending confirmation from the company; do not treat any digits shown as the live number until replaced. The site's previous placeholder phone number sitewide has been retired and must not recur.

Manufacturing site

MIDC Tarapur, Boisar, Maharashtra — the single point of production

MIDC Tarapur, Boisar, Maharashtra, India

D-U-N-S® Number 915076185

Phone
[Phone pending — company input]
Email
[Email pending — company input]

EU-GMP · ANVISA (Brazil) · INVIMA (Colombia) · UAE MOHAP · NHRA Bahrain · WHO-GMP

Pending approval Plant phone/fax and site-specific email shown on this card are clearly-labeled stand-ins pending confirmation from the company; the street-level address and DUNS number are corroborated, the contact digits are not.

General enquiries

Send a routed enquiry

The enquiry form below asks for enquiry type (export/regulatory, CDMO/partnership, careers, other), company name, country, and message — the same routing categories described above. Product complaints and adverse-event reports are not accepted through this form; use the pharmacovigilance path instead.

Product complaints and adverse-event reports are not accepted through this form — use the pharmacovigilance path below instead.

Pending approval Form submission handling (endpoint, storage, and acknowledgment email) is not yet wired for this prototype; treat the form as a static placeholder pending backend integration in a later build stage.

Product complaints & adverse events

Pharmacovigilance and product-complaint reporting

Report a suspected product quality complaint or an adverse event linked to a Naprod-manufactured product through this dedicated path — not the general enquiry form. This channel is for regulated reporting only: batch-specific quality deviations, packaging or labeling defects, and adverse-event observations tied to a specific product and batch number. Reports are logged against the Tarapur facility's quality management system, the same system underlying its EU-GMP, ANVISA, INVIMA, UAE Ministry of Health, NHRA Bahrain, and WHO-GMP accreditations.

Reporting email
pharmacovigilance@naprodgroup.com
Reporting phone
[Phone pending — company input]
Report a product complaint

Pending approval The pharmacovigilance intake address/phone and the internal SLA for acknowledgment are pending confirmation from the company; this section is a placeholder path, visibly labeled, until the company supplies a live reporting channel. This site makes no medical or therapeutic-benefit claims — this path exists for quality and safety reporting only, not clinical advice.